It reduces amyloid load and tau phosphorylation in Alzheimer’s disease [50,51,52], as well as dopaminergic cell death in Parkinson’s disease [53], and favors neurogenesis and synaptogenesis [54]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.